Activity Overview

This educational activity is an archive of the live conference held on February 21, 2026.

Target Audience

This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists, pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in treating melanoma and other cutaneous malignancies will also be invited to participate.

Learning Objectives

Determine the role of biomarkers in developing personalized treatment plans for patients with skin cancers
Devise management protocols aligned with best practices for treating melanomas, squamous cell carcinoma, basal cell carcinoma, and other skin malignancies

Module 1: Early-Line Treatment of Cutaneous Melanoma

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.25 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Castle Biosciences, Inc; Immatics; Immunocore; and Obsidian Therapeutics.

Module 1: Early-Line Treatment of Cutaneous Melanoma

Sapna Patel, MD

Omid Hamid, MD

James M.G. Larkin, MD, PhD

John B.A.G. Haanen, MD, PhD

Meredith McKean, MD, MPH

Yana G. Najjar, MD

April K.S. Salama, MD

Ryan J. Sullivan, MD

GET STARTED WITH THIS PROGRAM:

You Also Might Like...

Community Practice Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy–Strategies for the Multidisciplinary Team

22nd Annual International Symposium on Melanoma and Other Cutaneous Malignancies® - Learning Hub

23rd Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Medical Crossfire®: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical Application